Literature DB >> 15086872

Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells.

S C Bischoff1, S Schwengberg, A Lorentz, M P Manns, H Bektas, H Sann, F Levi-Schaffer, F Shanahan, M Schemann.   

Abstract

Neuropeptides such as substance P (SP) and related peptides are supposed to act as mast cell agonists, and thus as mediators of neuroimmune interactions. The data supporting this hypothesis were obtained mostly from rodent experiments. Here, we studied for the first time the effect of SP and other peptides on mediator release in human intestinal mast cells, either unpurified or enriched to 85-99% purity. We found that SP at 0.1-100 micromol L(-1), or other peptides including neurokinin A and B, calcitonin gene-related peptide, vasoactive intestinal peptide and serotonin at 1 micromol L(-1) do not induce release of mediators such as histamine, sulphidoleukotrienes, and tumour necrosis factor alpha. The peptides also failed to cause mediator release in mast cells isolated from inflamed tissue derived from Crohn's disease. Using reverse transcriptase-polymerase chain reaction, flow cytometry and immunohistochemistry, we could show that human intestinal mast cells do not express the tachykinin receptors NK-1, NK-2, or NK-3 under basal conditions. However, upon stimulation by immunoglobulin E (IgE) receptor-crosslinking, which induces an extensive mediator release reaction, a subpopulation of mast cells clearly expressed NK-1, the SP receptor. In conclusion, our data show that SP and other neuropeptides do not act as secretagogues in human intestinal mast cells that have not been pre-activated by IgE receptor-crosslinking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086872     DOI: 10.1111/j.1365-2982.2004.00502.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  15 in total

1.  Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

Authors:  Martin Metz; Clemens Krull; Tomasz Hawro; Rohit Saluja; Adriane Groffik; Christian Stanger; Petra Staubach; Marcus Maurer
Journal:  J Invest Dermatol       Date:  2014-05-20       Impact factor: 8.551

Review 2.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

3.  Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell.

Authors:  Carole A Oskeritzian; Wei Zhao; Hae-Ki Min; Han-Zhang Xia; Andrea Pozez; Jonathan Kiev; Lawrence B Schwartz
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

4.  Significance of Conversation between Mast Cells and Nerves.

Authors:  Hanneke Pm van der Kleij; John Bienenstock
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

Review 5.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

6.  Neuropeptides activate human mast cell degranulation and chemokine production.

Authors:  Marianna Kulka; Cecilia H Sheen; Brian P Tancowny; Leslie C Grammer; Robert P Schleimer
Journal:  Immunology       Date:  2007-10-06       Impact factor: 7.397

Review 7.  Mast cells: versatile gatekeepers of pain.

Authors:  Devavani Chatterjea; Tijana Martinov
Journal:  Mol Immunol       Date:  2014-03-22       Impact factor: 4.407

8.  Mast cell-nerve interaction in the colon of Trypanosoma cruzi-infected individuals with chagasic megacolon.

Authors:  Patrícia Rocha Martins; Rodolfo Duarte Nascimento; Aline Tomaz Dos Santos; Enio Chaves de Oliveira; Patricia Massara Martinelli; Débora d'Avila Reis
Journal:  Parasitol Res       Date:  2018-02-22       Impact factor: 2.289

9.  Disodium cromoglycate inhibits capsaicin-induced eosinophil infiltration of conjunctiva independent of mast cells.

Authors:  Nobuyuki Ebihara; Motoaki Nishikawa; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.211

Review 10.  Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases.

Authors:  Monica Thapaliya; Chalatip Chompunud Na Ayudhya; Aetas Amponnawarat; Saptarshi Roy; Hydar Ali
Journal:  Curr Allergy Asthma Rep       Date:  2021-01-04       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.